FRESENIUS MEDICAL CARE NORTH AMERICA

Lobbying for FRESENIUS MEDICAL CARE NORTH AMERICA

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 16, 2026

Expenses

$1,220,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

Centers For Medicare and Medicaid Services (CMS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 4

HR 2199
Restore Protections for Dialysis Patients Act
S 1173
Restore Protections for Dialysis Patients Act
HR 6214
Kidney Care Access Protection Act
S 2730
Kidney Care Access Protection Act

Lobbying activity 2

Medicare/Medicaid

H.R. 2199/S. 1173- Restore Protections for Dialysis Patients Act Implementation of the "One Big, Beautiful Bill" Act.-P.L. 119-21 The VA/MILCON Appropriations Subcommittee bill. H.R. 6214/S. 2730 - Kidney Care Access Protection Act Medicare and Medicaid coverage End Stage Renal Disease (ESRD) Prospective Payment System (PPS) Kidney Care Choices Model and Skin Substitutes

Tariff (miscellaneous tariff bills)

Tariffs

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.